The California Institute for Regenerative Medicine (CIRM) is pleased to announce the next round of funding opportunities for Translational (TRAN) research projects. Click here to access the Program Announcement.
The objective of this program is to fund promising stem cell-based and gene therapy projects that accelerate completion of translational stage activities necessary for advancement to clinical study or broad end use. These may include:
- TRAN 1: Stem cell-based or gene therapy therapeutic candidate
- TRAN 2: Diagnostic based on stem cells or critical for stem cell-based or genetic therapy development or use
- TRAN 3: Medical device (non-diagnostic) for a stem cell-based therapy or critical for stem cell-based or genetic therapy development or use
- TRAN 4: Novel tool that addresses a critical bottleneck to the discovery or development of stem cell-based or genetic therapy
Successful CIRM translational research projects that meet the program objective will be in position to progress rapidly to our Clinical Stage Programs.
Applications are due June 13th, 2023 at 2pm PDT.
Visit our website for more details on how to apply. We look forward to your applications!